Literature DB >> 7635291

A transgenic mouse assay for agouti protein activity.

W L Perry1, C M Hustad, D A Swing, N A Jenkins, N G Copeland.   

Abstract

The mouse agouti gene encodes an 131 amino acid paracrine signaling molecule that instructs hair follicle melanocytes to switch from making black to yellow pigment. Expression of agouti during the middle part of the hair growth cycle in wild-type mice produces a yellow band on an otherwise black hair. The ubiquitous unregulated expression of agouti in mice carrying dominant yellow alleles is associated with pleiotropic effects including increased yellow pigment in the coat, obesity, diabetes and increased tumor susceptibility. Agouti shows no significant homology to known genes, and the molecular analysis of agouti alleles has shed little new light on the important functional elements of the agouti protein. In this paper, we show that agouti expression driven by the human beta-ACTIN promoter produces obese yellow transgenic mice and that this can be used as an assay for agouti activity. We used this assay to evaluate a point mutation associated with the a16H allele within the region encoding agouti's putative signal sequence and our results suggest that this mutation is sufficient to cause the a16H phenotype. Thus, in vitro mutagenesis followed by the generation of transgenic mice should allow us to identify important functional elements of the agouti protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635291      PMCID: PMC1206553     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  28 in total

1.  Physiologic observations on yellow obesity in the mouse.

Authors:  K J CARPENTER; J MAYER
Journal:  Am J Physiol       Date:  1958-06

2.  PCR amplification of long DNA fragments.

Authors:  M R Ponce; J L Micol
Journal:  Nucleic Acids Res       Date:  1992-02-11       Impact factor: 16.971

3.  Differential responses of yellow Avy/A and agouti A/a (BALB/c X VY) F1 hybrid mice to the same diets: glucose tolerance, weight gain, and adipocyte cellularity.

Authors:  L G Frigeri; G L Wolff; C Teguh
Journal:  Int J Obes       Date:  1988

4.  Genetically transmitted obesity in rodents.

Authors:  G A Bray; D A York
Journal:  Physiol Rev       Date:  1971-07       Impact factor: 37.312

5.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

Review 6.  Obesity, diabetes, and neoplasia in yellow A(vy)/- mice: ectopic expression of the agouti gene.

Authors:  T T Yen; A M Gill; L G Frigeri; G S Barsh; G L Wolff
Journal:  FASEB J       Date:  1994-05       Impact factor: 5.191

7.  Coinjection strategy for visual identification of transgenic mice.

Authors:  P A Overbeek; E Aguilar-Cordova; G Hanten; D L Schaffner; P Patel; R M Lebovitz; M W Lieberman
Journal:  Transgenic Res       Date:  1991-12       Impact factor: 2.788

8.  Differential expression of a new dominant agouti allele (Aiapy) is correlated with methylation state and is influenced by parental lineage.

Authors:  E J Michaud; M J van Vugt; S J Bultman; H O Sweet; M T Davisson; R P Woychik
Journal:  Genes Dev       Date:  1994-06-15       Impact factor: 11.361

9.  Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation.

Authors:  M W Miller; D M Duhl; H Vrieling; S P Cordes; M M Ollmann; B M Winkes; G S Barsh
Journal:  Genes Dev       Date:  1993-03       Impact factor: 11.361

10.  Molecular genetic characterization of six recessive viable alleles of the mouse agouti locus.

Authors:  C M Hustad; W L Perry; L D Siracusa; C Rasberry; L Cobb; B M Cattanach; R Kovatch; N G Copeland; N A Jenkins
Journal:  Genetics       Date:  1995-05       Impact factor: 4.562

View more
  9 in total

1.  Molecular and phenotypic analysis of 25 recessive, homozygous-viable alleles at the mouse agouti locus.

Authors:  Rosalynn J Miltenberger; Kazumasa Wakamatsu; Shosuke Ito; Richard P Woychik; Liane B Russell; Edward J Michaud
Journal:  Genetics       Date:  2002-02       Impact factor: 4.562

Review 2.  Do transgene arrays form heterochromatin in vertebrates?

Authors:  D R Dorer
Journal:  Transgenic Res       Date:  1997-01       Impact factor: 2.788

3.  Variegated expression of a globin transgene correlates with chromatin accessibility but not methylation status.

Authors:  D Garrick; H Sutherland; G Robertson; E Whitelaw
Journal:  Nucleic Acids Res       Date:  1996-12-15       Impact factor: 16.971

4.  Coupled site-directed mutagenesis/transgenesis identifies important functional domains of the mouse agouti protein.

Authors:  W L Perry; T Nakamura; D A Swing; L Secrest; B Eagleson; C M Hustad; N G Copeland; N A Jenkins
Journal:  Genetics       Date:  1996-09       Impact factor: 4.562

5.  Alu-mediated 100-kb deletion in the primate genome: the loss of the agouti signaling protein gene in the lesser apes.

Authors:  Kazuhiro Nakayama; Takafumi Ishida
Journal:  Genome Res       Date:  2006-04       Impact factor: 9.043

6.  Characterization of the dog Agouti gene and a nonagoutimutation in German Shepherd Dogs.

Authors:  Julie A Kerns; J Newton; Tom G Berryere; Edward M Rubin; Jan-Fang Cheng; Sheila M Schmutz; Gregory S Barsh
Journal:  Mamm Genome       Date:  2004-10       Impact factor: 2.957

7.  An agouti mutation lacking the basic domain induces yellow pigmentation but not obesity in transgenic mice.

Authors:  R J Miltenberger; R L Mynatt; B D Bruce; W O Wilkison; R P Woychik; E J Michaud
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

8.  Molecular basis of the pleiotropic phenotype of mice carrying the hypervariable yellow (Ahvy) mutation at the agouti locus.

Authors:  A C Argeson; K K Nelson; L D Siracusa
Journal:  Genetics       Date:  1996-02       Impact factor: 4.562

Review 9.  Melanocortin-3 receptors and metabolic homeostasis.

Authors:  Karima Begriche; Clemencé Girardet; Patricia McDonald; Andrew A Butler
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.